These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3293394)

  • 21. Antianginal and anti-ischemic efficacy of nisoldipine in stable angina pectoris: a randomized, double-blind, placebo-controlled trial.
    Chen YH; Liu RC; Wang SP
    Zhonghua Yi Xue Za Zhi (Taipei); 1996 Nov; 58(5):323-8. PubMed ID: 9037847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dose-related haemodynamic effects of nicardipine during rest and exercise and variable anti-anginal effects in patients with chronic stable angina.
    Thomassen AR; Bagger JP; Nielsen TT; Henningsen P
    Eur Heart J; 1987 Mar; 8(3):271-6. PubMed ID: 3582386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antianginal and anti-ischemic effects of mibefradil in the treatment of patients with chronic stable angina pectoris.
    Alpert JS; Bakx AL; Braun S; Frishman WH; Schneeweiss A; Tzivoni D; Kobrin I
    Am J Cardiol; 1997 Aug; 80(4B):20C-26C. PubMed ID: 9286850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amlodipine combined with beta blockade for chronic angina: results of a multicenter, placebo-controlled, randomized double-blind study.
    DiBianco R; Schoomaker FW; Singh JB; Awan NA; Bennett T; Canosa FL; Kawanishi DT; Bamrah VS; Glasser SP; Barry W
    Clin Cardiol; 1992 Jul; 15(7):519-24. PubMed ID: 1354085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.
    Frampton JE; Faulds D
    Drugs Aging; 1993; 3(2):165-87. PubMed ID: 8477149
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
    McClellan KJ; Plosker GL
    Drugs; 1999 Jul; 58(1):143-57. PubMed ID: 10439934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nicardipine--a new calcium-entry blocker.
    Med Lett Drugs Ther; 1989 May; 31(791):41-2. PubMed ID: 2710026
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of vasospastic angina with nicardipine.
    Pepine CJ; Gelman JS
    Br J Clin Pharmacol; 1985; 20 Suppl 1(Suppl 1):187S-194S. PubMed ID: 3896281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
    Thadani U; Zellner SR; Glasser S; Bittar N; Montoro R; Miller AB; Chaitman B; Schulman P; Stahl A; DiBianco R
    Circulation; 1991 Dec; 84(6):2398-408. PubMed ID: 1959195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.
    Hollingshead LM; Faulds D; Fitton A
    Drugs; 1992 Nov; 44(5):835-57. PubMed ID: 1280569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients.
    DiBianco R; Alpert J; Katz RJ; Spann J; Chesler E; Ferri DP; Larca LJ; Costello RB; Gore JM; Eisenman MJ
    Am J Cardiol; 1984 Jan; 53(1):35-41. PubMed ID: 6362386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative haemodynamic effects of nicardipine and verapamil in coronary artery disease.
    Silke B; Verma SP; Hussain M; Jackson NC; Hafizullah M; Reynolds G; Taylor SH
    Herz; 1985 Apr; 10(2):112-9. PubMed ID: 3872835
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term combined dosing with nicardipine and propranolol on coronary hemodynamics, myocardial metabolism, and exercise tolerance in patients with angina pectoris: comparison with monotherapy.
    Hanet C; Pouleur H; Harlow BJ; Rousseau MF
    Am Heart J; 1988 Aug; 116(2 Pt 1):431-9. PubMed ID: 3041788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamics of nicardipine in coronary artery disease.
    Visser CA; Koolen JJ; van Wezel H; Dunning AJ
    Am J Cardiol; 1987 Jun; 59(17):9J-12J. PubMed ID: 3300240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improvement in left ventricular diastolic function in patients with stable angina after chronic treatment with verapamil and nicardipine.
    Rodrigues EA; Lahiri A; Raftery EB
    Eur Heart J; 1987 Jun; 8(6):624-9. PubMed ID: 3622543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Usefulness of PY 108-068, a new calcium channel blocker, for angina pectoris.
    de Buitleir M; Krikler S; Krikler DM
    Am J Cardiol; 1986 Jan; 57(1):15-9. PubMed ID: 3079940
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mibefradil, a T-type channel-selective calcium antagonist: clinical trials in chronic stable angina pectoris.
    Massie BM
    Am J Hypertens; 1998 Apr; 11(4 Pt 3):95S-102S. PubMed ID: 9607373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of invasive ergometric exercise to assess the hemodynamic response to nicardipine.
    Cody RJ
    Am J Cardiol; 1987 Jun; 59(17):20J-24J. PubMed ID: 3604921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Haemodynamic effects of intravenous nicardipine during upright exercise in patients with stable angina pectoris.
    Jackson NC; Silke B; Verma SP; Reynolds G; Hafizullah M; Taylor SH
    Postgrad Med J; 1984; 60 Suppl 4():11-6. PubMed ID: 6527973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.